当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Xofluza (baloxavir marboxil)
药品名称
Xofluza (baloxavir marboxil)
承诺描述
Evaluate the impact of the following substitutions on the susceptibility of influenza virus to baloxavir in cell culture: PA substitutions R269I, V330I, K328E and T363I in A/H1N1 virus and I554V in A/H3N2 virus.